EE03003B1 - Angiotensiin II retseptorite antagonistidena toimivad triasolopürimidiinide derivaadid, ravimvormid, nende valmistamise meetodid - Google Patents

Angiotensiin II retseptorite antagonistidena toimivad triasolopürimidiinide derivaadid, ravimvormid, nende valmistamise meetodid

Info

Publication number
EE03003B1
EE03003B1 EE9400308A EE9400308A EE03003B1 EE 03003 B1 EE03003 B1 EE 03003B1 EE 9400308 A EE9400308 A EE 9400308A EE 9400308 A EE9400308 A EE 9400308A EE 03003 B1 EE03003 B1 EE 03003B1
Authority
EE
Estonia
Prior art keywords
angiotensin
formulations
preparation
methods
receptor antagonists
Prior art date
Application number
EE9400308A
Other languages
English (en)
Estonian (et)
Inventor
Bru-Magniez Nicole
Nicolai Eric
Teulon Jean-Marie
Original Assignee
Laboratoires Upsa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Upsa filed Critical Laboratoires Upsa
Publication of EE03003B1 publication Critical patent/EE03003B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EE9400308A 1991-07-05 1994-11-22 Angiotensiin II retseptorite antagonistidena toimivad triasolopürimidiinide derivaadid, ravimvormid, nende valmistamise meetodid EE03003B1 (et)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9108486A FR2678618B1 (fr) 1991-07-05 1991-07-05 Nouveaux derives de triazolo pyrimidine antagonistes des recepteurs a l'angiotensine ii; leurs procedes de preparation, compositions pharmaceutiques les contenant.

Publications (1)

Publication Number Publication Date
EE03003B1 true EE03003B1 (et) 1997-06-16

Family

ID=9414783

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9400308A EE03003B1 (et) 1991-07-05 1994-11-22 Angiotensiin II retseptorite antagonistidena toimivad triasolopürimidiinide derivaadid, ravimvormid, nende valmistamise meetodid

Country Status (23)

Country Link
US (1) US5217973A (da)
EP (1) EP0521768B1 (da)
JP (1) JP3140566B2 (da)
KR (1) KR100243628B1 (da)
AT (1) ATE101153T1 (da)
AU (1) AU655288B2 (da)
CA (1) CA2072233C (da)
CZ (1) CZ284757B6 (da)
DE (1) DE69200045T2 (da)
DK (1) DK0521768T3 (da)
EE (1) EE03003B1 (da)
ES (1) ES2063570T3 (da)
FR (1) FR2678618B1 (da)
HU (2) HU220225B (da)
IE (1) IE65635B1 (da)
IL (1) IL102367A (da)
LV (1) LV10717B (da)
MD (1) MD523G2 (da)
NZ (1) NZ243443A (da)
RU (1) RU2103270C1 (da)
SK (1) SK279902B6 (da)
TW (1) TW221445B (da)
ZA (1) ZA924954B (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5358950A (en) * 1991-07-05 1994-10-25 Laboratoires Upsa Triazolopyrimidine derivatives which are angiotensin II receptor antagonists
US5387747A (en) * 1992-02-24 1995-02-07 Laboratoires Upsa Triazolopyrimidine derivatives which are angiotensin II receptor antagonists, their methods of preparation and pharmaceutical compositions in which they are present
US5389632A (en) * 1992-02-24 1995-02-14 Laboratoires Upsa Pyrazolopyrimidine derivatives which are angiotensin II receptor antagonists
FR2687677B1 (fr) * 1992-02-24 1996-10-11 Union Pharma Scient Appl Nouveaux derives de polyazaindenes antagonistes des recepteurs a l'angiotensine ii ; leurs procedes de preparation, compositions pharmaceutiques les contenant.
IT1263804B (it) * 1993-01-22 1996-09-03 Luso Farmaco Inst Derivati pirimidinonici fusi con eterocicli azotati ad attivita' a ii antagonista
US5358947A (en) * 1993-09-13 1994-10-25 American Cyanamid Company Angiotensin II receptor blocking 2,3-substituted pyrazolo[1,5-a]-1,3,5-triazin-4(3H)-ones
ATE257156T1 (de) 1997-03-24 2004-01-15 Kyowa Hakko Kogyo Kk (1,2,4)triazolo(1,5-c)pyrimidin-derivate
SE9903028D0 (sv) 1999-08-27 1999-08-27 Astra Ab New use
DK2170930T3 (da) 2007-06-04 2012-11-05 Synergy Pharmaceuticals Inc Agonister af guanylatcyclase, anvendelige til behandlingen af gastrointestinale sygdomme, inflammation, cancer og andre sygdomme
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
GB0719803D0 (en) 2007-10-10 2007-11-21 Cancer Rec Tech Ltd Therapeutic compounds and their use
JP2011522828A (ja) 2008-06-04 2011-08-04 シナジー ファーマシューティカルズ インコーポレイテッド 胃腸障害、炎症、癌、およびその他の障害の治療のために有用なグアニル酸シクラーゼのアゴニスト
WO2009158309A2 (en) * 2008-06-25 2009-12-30 Ligand Pharmaceuticals Inc. Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
ES2624828T3 (es) 2008-07-16 2017-07-17 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
US9708367B2 (en) 2013-03-15 2017-07-18 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
AU2014235209B2 (en) 2013-03-15 2018-06-14 Bausch Health Ireland Limited Guanylate cyclase receptor agonists combined with other drugs
KR102272746B1 (ko) 2013-06-05 2021-07-08 보슈 헬스 아일랜드 리미티드 구아닐레이트 사이클라제 c의 초순수 작용제, 및 이의 제조 및 사용 방법
WO2023066299A1 (en) * 2021-10-19 2023-04-27 Impact Therapeutics (Shanghai) , Inc Substituted triazoloheteroaryl compounds as usp1 inhibitors and the use thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US269980A (en) * 1883-01-02 Horse power
GB859287A (en) * 1958-10-03 1961-01-18 Ici Ltd Triazolopyrimidine derivatives and their preparation
GB897870A (en) * 1959-06-15 1962-05-30 Ici Ltd s-triazolo[2, 3-c]pyrimidine derivatives
GB951652A (en) * 1960-06-28 1964-03-11 Wallace Broadbent Sulphamyl triazolopyrimidines and their preparation
US4269980A (en) * 1979-12-17 1981-05-26 American Cyanamid Company (Substituted-phenyl)-1,2,4-triazolo[4,3-c]pyrimidines and (substituted-phenyl)-1,2,4-triazolo[1,5-c]pyrimidines
US4572910A (en) * 1983-03-03 1986-02-25 Riker Laboratories, Inc. Triazolo[1,5-c]pyrimidines substituted by nitrogen-containing heterocyclic rings
US4528288A (en) * 1983-05-02 1985-07-09 Riker Laboratories, Inc. Substituted triazolo[1,5-c]pyrimidines
US4532242A (en) * 1983-05-02 1985-07-30 Riker Laboratories, Inc. Substituted triazolo[4,3-c]pyrimidines
US4562192A (en) * 1984-02-03 1985-12-31 G. D. Searle & Co. 6-Substituted-5-phenyltetrazolo[1,5-a][1,2,4]triazole[1,5-c]pyrimidines, and pharmaceutical compositions containing them
US4728652A (en) * 1985-05-20 1988-03-01 E. R. Squibb & Sons, Inc. 2-substituted thio or oxy-4-aryl or heterocyclo-5-carboxy-1,4-dihydropyrimidines, composition containing them, and method of using them to reduce blood pressure
US5010195A (en) * 1988-05-25 1991-04-23 The Dow Chemical Company Herbicidal alkoxy-1,2,4-triazolo(1,5-c)primidine-2-sulfonamides
US5073566A (en) * 1989-11-30 1991-12-17 Eli Lilly And Company Angiotensin ii antagonist 1,3-imidazoles and use thereas
EP0435827A3 (en) * 1989-12-28 1991-11-13 Ciba-Geigy Ag Diaza compounds
EP0522038A4 (en) * 1990-03-30 1993-05-26 Merck & Co. Inc. Substituted pyrimidines, pyrimidinones and pyridopyrimidines
US5177206A (en) * 1991-10-08 1993-01-05 Dowelanco Process for the preparation of substituted N-(aryl)-1,2,4-triazolopyrimidine-2-sulfonamides

Also Published As

Publication number Publication date
LV10717B (en) 1995-12-20
EP0521768B1 (fr) 1994-02-02
AU655288B2 (en) 1994-12-15
SK279902B6 (sk) 1999-05-07
RU2103270C1 (ru) 1998-01-27
FR2678618B1 (fr) 1993-11-05
SK207892A3 (en) 1995-08-09
CZ284757B6 (cs) 1999-02-17
AU1939692A (en) 1993-01-07
HU211473A9 (en) 1995-11-28
HU9202227D0 (en) 1992-10-28
ES2063570T3 (es) 1995-01-01
EP0521768A1 (fr) 1993-01-07
IL102367A (en) 1997-06-10
MD523G2 (ro) 1997-01-31
JPH06122685A (ja) 1994-05-06
KR930002349A (ko) 1993-02-23
ATE101153T1 (de) 1994-02-15
DE69200045T2 (de) 1994-05-19
HU220225B (hu) 2001-11-28
TW221445B (da) 1994-03-01
CZ207892A3 (en) 1993-01-13
CA2072233C (en) 2003-11-18
NZ243443A (en) 1995-01-27
MD523F1 (en) 1996-04-30
DE69200045D1 (de) 1994-03-17
IL102367A0 (en) 1993-01-14
CA2072233A1 (en) 1993-01-06
US5217973A (en) 1993-06-08
FR2678618A1 (fr) 1993-01-08
HUT63422A (en) 1993-08-30
ZA924954B (en) 1993-04-28
LV10717A (lv) 1995-06-20
JP3140566B2 (ja) 2001-03-05
KR100243628B1 (ko) 2000-03-02
DK0521768T3 (da) 1994-08-15
IE65635B1 (en) 1995-11-01
IE922015A1 (en) 1993-01-13

Similar Documents

Publication Publication Date Title
EE03003B1 (et) Angiotensiin II retseptorite antagonistidena toimivad triasolopürimidiinide derivaadid, ravimvormid, nende valmistamise meetodid
MX9201317A (es) Nuevos derivados de imidazo pirina, procedimiento para su preparacion y composicion farmaceutica que los contiene.
NO992524L (no) Konsenserte bicykliske pyrimidin-derivater
TR199800436A2 (xx) Primidin t�revlerinin kanserin �nlenmesi i�in kullan�lmas�.
RU92004368A (ru) Замещенные пиримидины, способ их получения, фармацевтическая композиция
RU94038256A (ru) Производные пиразолопиримидина, способ их получения, фармацевтические композиции на их основе
ES8505379A1 (es) Un metodo de fabricar 1, 4-dihidropiridina-3-carboxilatos
NZ221611A (en) Imidazolylguanidine derivatives and pharmaceutical compositions
EE03046B1 (et) Angiotensiin II retseptorite antagonistide triasolopürimidiinide derivaadid, nende valmistamise meetod ja ravimvormid
NO883262D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive piperidinderivater.
IT1275935B1 (it) Derivato di aminotetralina per la terapia di malattie cardiovascolari
SE8402199L (sv) Farmaceutiskt preparat innehallande co-dergocrin och en kalciumantagonist
NZ220539A (en) 1,4-dihydropyridine derivatives and pharmaceutical compositions
SE8603517L (sv) Heterocykliska foreningar och deras framstellning och farmaceutiska formuleringar
RU92016587A (ru) Новые производные бензопирана, активатор калиевого канала
IT1251496B (it) Derivati imidazotiadiazolici ad attivita' diuretica, procedimenti per la loro preparazione e composizioni che li contengono

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20091231

KB4A Valid patent at the end of a year

Effective date: 20101231